The 20 Best Bladder Reconstruction Doctors Near Me

Find the Experts and Specialists who perform Bladder Reconstruction

OverviewFind a DoctorLatest AdvancesClinical Trials
Seth P. Lerner
Advanced in Bladder Reconstruction

Dr. Seth P. Lerner

Oncology | Surgical Oncology | Urology
CommonSpirit Health
Baylor Medicine At McNair - Urology
7200 Cambridge St., 10th Floor, Suite 10 B, 
Houston, TX 
Accepting New Patients
Offers Telehealth

Advanced in Bladder Reconstruction
CommonSpirit Health
Baylor Medicine At McNair - Urology
7200 Cambridge St., 10th Floor, Suite 10 B, 
Houston, TX 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Seth P. Lerner, MD, is Professor of Urology and holds the Beth and Dave Swalm Chair in Urologic Oncology, in the Scott Department of Urology, Baylor College of Medicine. He is Director of Urologic Oncology and the Multidisciplinary Bladder Cancer Program and Faculty Group Practice Medical Director for the Urology Clinic. He earned his medical degree from Baylor College of Medicine, completed a surgical internship at Virginia Mason Hospital in Seattle, and returned to Baylor for his residency training. He completed a two-year fellowship at the University of Southern California in urologic oncology and reconstructive surgery under Peter Jones and Don Skinner before returning to join the full-time Baylor faculty in 1992. His clinical practice, education, and research activities are devoted to urologic oncology and particularly lower and upper tract urothelial cancer. Dr. Lerner is author of more than 160 peer-reviewed articles, and co-editor of a comprehensive Textbook of Bladder Cancer. Dr. Lerner is an active member of the prestigious American Association of Genitourinary surgeons and is listed routinely among America's Top Doctors and Best Doctors in America. He established and directs the multi-disciplinary Bladder Cancer Research Program at Baylor, and his research interests include use of selective estrogen receptor modulators for treatment of bladder cancer, gene therapy, targeted molecular therapeutics, and outcomes of radical cystectomy and pelvic lymphadenectomy. He has 22 years of experience as a clinical investigator for both NCI and industry funded clinical trials. He is the PI of the ongoing SWOG NCI Phase III trial comparing extended vs. standard pelvic lymphadenectomy at time of radical cystectomy for muscle invasive bladder cancer. He is active in the leadership of several national bladder cancer research enterprises including chair of the Local Bladder Cancer committee of SWOG, co-chair of the NCI's Bladder Cancer Task Force and the Analysis Working Group of The Cancer Genome Atlas Project for muscle invasive bladder cancer. He is very active in the Bladder Cancer Advocacy Network (BCAN) as a member of the Board of Directors, past chair of the Bladder Cancer Think Tank and co-chair of the management committee of the Bladder Cancer Research Network.

Dr. Lerner is rated as an Advanced provider by MediFind in Bladder Reconstruction. His top areas of expertise are Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Cystectomy, and Lymphadenectomy.

His clinical research consists of co-authoring 203 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Bladder Reconstruction.

Graduate Institution
Baylor College Of Medicine
Specialties
Oncology
Surgical Oncology
Urology
Licenses
Urology in TX
Hospital Affiliations
Baylor St. Luke's Medical Center - Houston, TX
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Community Health
  • EPO
  • HMO
Community Health Choice
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

Baylor Medicine at McNair - Urology
7200 Cambridge St., 10th Floor, Suite 10 B, Houston, TX 77030
Call: 713-798-4001

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


9 Clinical Trials

Phase II Trial of Intravesical Gemcitabine and MK-3475 (Pembrolizumab) in the Treatment of Patients With BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Phase II Trial of Intravesical Gemcitabine and MK-3475 (Pembrolizumab) in the Treatment of Patients With BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Enrollment Status: Active_not_recruiting
Publish Date: February 12, 2026
Intervention Type: Procedure, Drug, Biological
Study Drugs: Gemcitabine Hydrochloride, Pembrolizumab
Study Phase: Phase 2
Genetic Susceptibility to Bladder Cancer: A Molecular Epidemiology Approach
Genetic Susceptibility to Bladder Cancer: A Molecular Epidemiology Approach
Enrollment Status: Active_not_recruiting
Publish Date: January 14, 2026
Intervention Type: Behavioral
A Phase 3 Study of Cretostimogene Grenadenorepvec in Patients With Non-Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Bacillus-Calmette-Guerin (BCG)
A Phase 3 Study of Cretostimogene Grenadenorepvec in Patients With Non-Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Bacillus-Calmette-Guerin (BCG)
Enrollment Status: Active_not_recruiting
Publish Date: July 03, 2025
Intervention Type: Other, Biological
Study Drugs: CG0070, N-Dodecyl-B-D-Maltoside
Study Phase: Phase 3
Phase II Trial of Atezolizumab in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Phase II Trial of Atezolizumab in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Enrollment Status: Completed
Publish Date: May 22, 2025
Intervention Type: Drug
Study Drug: Atezolizumab
Study Phase: Phase 2
S1602, A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming With Intradermal BCG Before Intravesical Therapy for BCG-Naive High-Grade Non-muscle Invasive Bladder Cancer
S1602, A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming With Intradermal BCG Before Intravesical Therapy for BCG-Naive High-Grade Non-muscle Invasive Bladder Cancer
Enrollment Status: Active_not_recruiting
Publish Date: April 02, 2025
Intervention Type: Biological, Other
Study Drugs: Bacillus of Calmette-Guerin, Bacillus of Calmette-Guerin Tokyo-172 Strain Solution, Bacillus of Calmette-Guerin Tokyo-172 Strain Vaccine
Study Phase: Phase 3
A Phase III Surgical Trial to Evaluate the Benefit of a Standard Versus an Extended Pelvic Lymphadenectomy Performed at Time of Radical Cystectomy for Muscle Invasive Urothelial Cancer
A Phase III Surgical Trial to Evaluate the Benefit of a Standard Versus an Extended Pelvic Lymphadenectomy Performed at Time of Radical Cystectomy for Muscle Invasive Urothelial Cancer
Enrollment Status: Completed
Publish Date: November 29, 2024
Intervention Type: Procedure
Study Phase: Not Applicable
Bacillus Calmette-Guerin Vaccination as Defense Against SARS-CoV-2: A Randomized Controlled Trial to Protect Health Care Workers by Enhanced Trained Immune Responses
Bacillus Calmette-Guerin Vaccination as Defense Against SARS-CoV-2: A Randomized Controlled Trial to Protect Health Care Workers by Enhanced Trained Immune Responses
Enrollment Status: Completed
Publish Date: October 08, 2024
Intervention Type: Biological
Study Drug: Bacillus of Calmette-Guerin Vaccine
Study Phase: Phase 4
Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial of Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations (PROOF 302)
Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial of Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations (PROOF 302)
Enrollment Status: Terminated
Publish Date: March 13, 2024
Intervention Type: Drug
Study Drug: Infigratinib
Study Phase: Phase 3
A Window of Opportunity Trial: Avelumab in Non-metastatic Muscle Invasive Bladder Cancer (BL-AIR: Bladder Cancer-Avelumab for Invasive Resectable Disease)
A Window of Opportunity Trial: Avelumab in Non-metastatic Muscle Invasive Bladder Cancer (BL-AIR: Bladder Cancer-Avelumab for Invasive Resectable Disease)
Enrollment Status: Terminated
Publish Date: August 24, 2020
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
View 8 Less Clinical Trials

202 Total Publications

Systemic Therapy for Muscle-Invasive Urothelial Carcinoma of the Bladder (Muscle-Invasive Bladder Cancer): Insights From Real-World Data.
Systemic Therapy for Muscle-Invasive Urothelial Carcinoma of the Bladder (Muscle-Invasive Bladder Cancer): Insights From Real-World Data.
Journal: JCO oncology practice
Published: November 18, 2025
View All 202 Publications
Similar Doctors
Atif Iqbal
Advanced in Bladder Reconstruction
Dr. Atif Iqbal
Colorectal Surgery | Oncology | General Surgery
Advanced in Bladder Reconstruction
Dr. Atif Iqbal
Colorectal Surgery | Oncology | General Surgery

Baylor College Of Medicine

6620 Main St, Suite 1375, 
Houston, TX 
 (0.8 miles away)
713-798-1000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Dr. Atif Iqbal specializes in surgical procedures for benign and malignant pathology of the colon, rectum and anus. Dr. Iqbal is an Associate Professor and Chief, Section of Colorectal Surgery - Surgical Oncology at Baylor College of Medicine, where he is a member of the Dan L Duncan Comprehensive Cancer Center. Dr. Iqbal’s clinical interests include: robotic surgery and advanced laparoscopy, including sphincter saving procedures for low rectal cancer; and pelvic surgery and surgical treatment of rectal cancer, including transanal endoscopic microsurgery. He is a member of the Baylor Inflammatory Bowel Disease Center and offers laparoscopic pouch procedures for ulcerative colitis and minimally invasive surgery for Crohn’s disease.His research interests include: health services and outcome-based translational research in colorectal pathology with a focus on rectal cancer outcomes and institution of enhanced recovery programs after surgery.Dr. Iqbal earned his medical degree from King Edward Medical University and completed an internship in surgery at Mayo Hospital, in Lahore, Pakistan. He completed a surgical research fellowship at Creighton University Medical Center in Omaha, Nebraska and his residency in general surgery at the University of Missouri, followed by a fellowship in colon and rectal surgery at Washington University/Barnes-Jewish Hospital in St. Louis. He joined the faculty of the University of Florida where he was an associate professor.Dr. Iqbal is a member of Alpha Omega Alpha medical honor society. He is currently serving as an elected surgical expert on the NCI Rectal-Anal Task Force and the Colon task force of the GI steering committee. He is a member of the American College of Surgeons, American Society of Colon and Rectal Surgeons, and NRG Oncology. Dr. Iqbal has earned honors for his research presentations to the ACS, SAGES and the Commission on Cancer, as well as a medal of achievement in physiology by the Pakistan Physiological Research Organization. He has also earned numerous ‘patient nominations’ and awards for the quality of care provided. Dr. Iqbal has also been named a Top Doctor in Colon and Rectal Surgery by Houstonia Magazine (2020). Dr. Iqbal is rated as an Advanced provider by MediFind in Bladder Reconstruction. His top areas of expertise are Familial Colorectal Cancer, Anal Cancer, Genital Warts, Bladder Reconstruction, and Hernia Surgery.

Advanced in Bladder Reconstruction
Dr. Rose Khavari
Urology
Advanced in Bladder Reconstruction
Dr. Rose Khavari
Urology

Office

6560 Fannin St Ste 2100, 
Houston, TX 
 (0.6 miles away)
713-903-2837
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Rose Khavari is a Urologist in Houston, Texas. Dr. Khavari is rated as a Distinguished provider by MediFind in Bladder Reconstruction. Her top areas of expertise are Neurogenic Bladder, Urinary Incontinence, Stress Urinary Incontinence, Bladder Reconstruction, and Reconstructive Urology Surgery.

Experienced in Bladder Reconstruction
Dr. Monty A. Aghazadeh
Urology | General Surgery
Experienced in Bladder Reconstruction
Dr. Monty A. Aghazadeh
Urology | General Surgery

Tmh Physician Associates PLLC

16605 Southwest Fwy 400 Mob3, Methodist Family Medicine, 
Sugar Land, TX 
 (16.0 miles away)
281-275-0800
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Monty Aghazadeh is a Urologist and a General Surgeon in Sugar Land, Texas. Dr. Aghazadeh is rated as an Advanced provider by MediFind in Bladder Reconstruction. His top areas of expertise are Urinary Tract Infection in Children, Cellulitis, Obstructive Uropathy, Ureteroscopy, and Cystectomy. Dr. Aghazadeh is currently accepting new patients.

VIEW MORE BLADDER RECONSTRUCTION DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Lerner's expertise for a condition
ConditionClose
  • Elite
  • Bladder Cancer
    Dr. Lerner is
    Elite
    . Learn about Bladder Cancer.
    See more Bladder Cancer experts
  • Cystectomy
    Dr. Lerner is
    Elite
    . Learn about Cystectomy.
    See more Cystectomy experts
  • Muscle Invasive Bladder Cancer
    Dr. Lerner is
    Elite
    . Learn about Muscle Invasive Bladder Cancer.
    See more Muscle Invasive Bladder Cancer experts
  • Non-Muscle Invasive Bladder Cancer
    Dr. Lerner is
    Elite
    . Learn about Non-Muscle Invasive Bladder Cancer.
    See more Non-Muscle Invasive Bladder Cancer experts
  • Urothelial Cancer
    Dr. Lerner is
    Elite
    . Learn about Urothelial Cancer.
    See more Urothelial Cancer experts
  • Distinguished
  • Lymphadenectomy
    Dr. Lerner is
    Distinguished
    . Learn about Lymphadenectomy.
    See more Lymphadenectomy experts
  • Upper Tract Urothelial Carcinoma (UTUC)
    Dr. Lerner is
    Distinguished
    . Learn about Upper Tract Urothelial Carcinoma (UTUC).
    See more Upper Tract Urothelial Carcinoma (UTUC) experts
  • Advanced
  • Bladder Reconstruction
    Dr. Lerner is
    Advanced
    . Learn about Bladder Reconstruction.
    See more Bladder Reconstruction experts
  • Hydronephrosis
    Dr. Lerner is
    Advanced
    . Learn about Hydronephrosis.
    See more Hydronephrosis experts
  • Nephrectomy
    Dr. Lerner is
    Advanced
    . Learn about Nephrectomy.
    See more Nephrectomy experts
  • Prostate Cancer
    Dr. Lerner is
    Advanced
    . Learn about Prostate Cancer.
    See more Prostate Cancer experts
  • Renal Cell Carcinoma (RCC)
    Dr. Lerner is
    Advanced
    . Learn about Renal Cell Carcinoma (RCC).
    See more Renal Cell Carcinoma (RCC) experts
  • Experienced
  • Adult Soft Tissue Sarcoma
    Dr. Lerner is
    Experienced
    . Learn about Adult Soft Tissue Sarcoma.
    See more Adult Soft Tissue Sarcoma experts
  • Bilateral Hydronephrosis
    Dr. Lerner is
    Experienced
    . Learn about Bilateral Hydronephrosis.
    See more Bilateral Hydronephrosis experts
  • Chromophobe Renal Cell Carcinoma
    Dr. Lerner is
    Experienced
    . Learn about Chromophobe Renal Cell Carcinoma.
    See more Chromophobe Renal Cell Carcinoma experts
  • Chronic B-Cell Leukemia (CBCL)
    Dr. Lerner is
    Experienced
    . Learn about Chronic B-Cell Leukemia (CBCL).
    See more Chronic B-Cell Leukemia (CBCL) experts
  • Chronic Lymphocytic Leukemia (CLL)
    Dr. Lerner is
    Experienced
    . Learn about Chronic Lymphocytic Leukemia (CLL).
    See more Chronic Lymphocytic Leukemia (CLL) experts
  • Clear Cell Sarcoma
    Dr. Lerner is
    Experienced
    . Learn about Clear Cell Sarcoma.
    See more Clear Cell Sarcoma experts
View All 23 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.